Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
McKesson
AstraZeneca
Julphar
Baxter
Fish and Richardson
Cerilliant
Cantor Fitzgerald
Johnson and Johnson

Generated: April 20, 2018

DrugPatentWatch Database Preview

AMIKIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

Which patents cover Amikin In Sodium Chloride 0.9% In Plastic Container, and when can generic versions of Amikin In Sodium Chloride 0.9% In Plastic Container launch?

Amikin In Sodium Chloride 0.9% In Plastic Container is a drug marketed by Apothecon and is included in one NDA.

The generic ingredient in AMIKIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is amikacin sulfate. There are fifteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the amikacin sulfate profile page.
Summary for AMIKIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Drug patent expirations by year for AMIKIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Medical Subject Heading (MeSH) Categories for AMIKIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

US Patents and Regulatory Information for AMIKIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon AMIKIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER amikacin sulfate INJECTABLE;INJECTION 050618-002 Nov 30, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apothecon AMIKIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER amikacin sulfate INJECTABLE;INJECTION 050618-001 Nov 30, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
UBS
QuintilesIMS
Cerilliant
Queensland Health
AstraZeneca
Teva
Express Scripts
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.